NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia.
Karle J, Clemmesen L, Hansen L, Andersen M, Andersen J, Fensbo C, Sloth-Nielsen M, Skrumsager BK, Lublin H, Gerlach J.
Karle J, et al. Among authors: skrumsager bk.
Psychopharmacology (Berl). 1995 Oct;121(3):328-9. doi: 10.1007/BF02246071.
Psychopharmacology (Berl). 1995.
PMID: 8584614
Clinical Trial.
No abstract available.